News search

    E.g., 25/04/2024
    E.g., 25/04/2024
    Imagen obtenida por microscopía confocal en la que se observa el borde de la cicatriz glial producida tras el infarto cerebral, lo cual dificulta la posterior regeneración de la zona. Este evento es atenuado en gran medida a través del tratamiento con metoprolol intravenoso pre-reperfusión.
    Research
    3 Oct 2022
    BJP: CNIC scientists identify a neuroprotective action of metoprolol after a stroke

    Metoprolol, an established drug in the cardiologists armory, protects the brain during a stroke and greatly reduces its consequences
    Research
    30 Aug 2021
    JACC: A drug costing less than €2 a day helps in the treatment of severely ill COVID-19 patients

    The safety, availability, and robust biological effect of metoprolol could together be enough to consider its use in young patients admitted to the ICU with severe COVID-19
    Research
    9 Oct 2020
    EHJ: Metoprolol: an old drug with unique cardioprotective properties

    CNIC scientists have defined the unique ability if metoprolol to protect the heart during a heart attack
    About the CNIC
    1 Jun 2017
    Dr. Borja Ibáñez awarded the XII Banco Sabadell Foundation Award for Biomedical Research

    Dr. Ibáñez, Director of Clinical Research at the CNIC, has received an award for his contribution to the fight against cardiovascular diseases
    Gonzalo Pizarro, David Sanz-Rosa, Borja Ibáñez, Jaime García-Prieto, Mónica Gómez, Rocío Villena, and Andrés Hidalgo.
    Research
    18 Apr 2017
    'Nature Communications': CNIC scientists discover how a decades-old drug reduces the size of a heart attack

    The beta-blocker metoprolol can limit cardiac damage in patients having a heart attack